Expression and Biologic Significance of Adiponectin Receptors in Papillary Thyroid Carcinoma

Cell Biochemistry and Biophysics

Volumn 65, Issue 2, 2013, Pages 203-210

  Cheng, Shih Ping ^a,b,c   Liu, Chien Liang ^a,b,d   Hsu, Yi Chiung ^e   Chang, Yuan Ching ^a   Huang, Shih Yuan ^a   Lee, Jie Jen ^a,b,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

Adiponectin; Adiponectin receptor; Leptin; Obesity; Thyroid cancer

Indexed keywords

EID: 84874226245     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9419-1     Document Type: Article

References (34)

1. Cramer, J. D., Fu, P., Harth, K. C., Margevicius, S., & Wilhelm, S. M. (2010). Analysis of the rising incidence of thyroid cancer using the surveillance, epidemiology and end results national cancer data registry. Surgery, 148, 1147-1152.
2. Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008). Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-578.
3. Leitzmann, M. F., Brenner, A., Moore, S. C., Koebnick, C., Park, Y., Hollenbeck, A., et al. (2010). Prospective study of body mass index, physical activity and thyroid cancer. International Journal of Cancer, 126, 2947-2956.
4. Cheng, S.-P., Chi, C.-W., Tzen, C.-Y., Yang, T.-L., Lee, J.-J., Liu, T.-P., et al. (2010). Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery, 147, 847-853.
5. Cheng, S.-P., Yin, P.-H., Chang, Y.-C., Lee, C.-H., Huang, S.-Y., & Chi, C.-W. (2010). Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncology Reports, 23, 1721-1727.
6. Cheng, S.-P., Yin, P.-H., Hsu, Y.-C., Chang, Y.-C., Huang, S.-Y., Lee, J.-J., et al. (2011). Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncology Reports, 26, 1265-1271.
7. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. The Journal of Biological Chemistry, 270, 26746-26749.
8. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications, 257, 79-83.
9. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-769.
10. Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., et al. (2004). Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. The Journal of Biological Chemistry, 279, 30817-30822.
11. Trujillo, M. E., & Scherer, P. E. (2005). Adiponectin-Journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine, 257, 167-175.
12. Kelesidis, I., Kelesidis, T., & Mantzoros, C. S. (2006). Adiponectin and cancer: a systematic review. British Journal of Cancer, 94, 1221-1225.
13. Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012). The role of adiponectin in cancer: A review of current evidence. Endocrine Reviews. doi: 10. 1210/er. 2011-1015 (in press).
14. Iglesias, P., Alvarez Fidalgo, P., Codoceo, R., & Diez, J. J. (2003). Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clinical Endocrinology, 59, 621-629.
15. Mitsiades, N., Pazaitou-Panayiotou, K., Aronis, K. N., Moon, H. S., Chamberland, J. P., Liu, X., et al. (2011). Circulating adiponectin is inversely associated with risk of thyroid cancer: In vivo and in vitro studies. The Journal of Clinical Endocrinology and Metabolism, 96, E2023-E2028.
16. Schweppe, R. E., Klopper, J. P., Korch, C., Pugazhenthi, U., Benezra, M., Knauf, J. A., et al. (2008). Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. The Journal of Clinical Endocrinology and Metabolism, 93, 4331-4341.
17. Cheng, S.-P., Lee, J.-J., Chi, C.-W., Chang, K.-M., & Chen, Y.-J. (2010). Platonin improves survival of skin allografts. Journal of Surgical Research, 164, 146-154.
18. Cady, B., & Rossi, R. (1988). An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104, 947-953.
19. Koerner, A., Kratzsch, J., & Kiess, W. (2005). Adipocytokines: Leptin-The classical, resistin-The controversial, adiponectin-The promising, and more to come. Best Practice & Research Clinical Endocrinology & Metabolism, 19, 525-546.
20. Vona-Davis, L., & Rose, D. P. (2007). Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocrine-Related Cancer, 14, 189-206.
21. Sun, J., Xu, Y., Dai, Z., & Sun, Y. (2009). Intermittent high glucose stimulate MCP-l, IL-18, and PAI-1, but inhibit adiponectin expression and secretion in adipocytes dependent of ROS. Cell Biochemistry and Biophysics, 55, 173-180.
22. Qiao, L., Schaack, J., & Shao, J. (2006). Suppression of adiponectin gene expression by histone deacetylase inhibitor valproic acid. Endocrinology, 147, 865-874.
23. Michalakis, K., Williams, C. J., Mitsiades, N., Blakeman, J., Balafouta-Tselenis, S., Giannopoulos, A., et al. (2007). Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study. Cancer Epidemiology, Biomarkers and Prevention, 16, 308-313.
24. Petridou, E. T., Mitsiades, N., Gialamas, S., Angelopoulos, M., Skalkidou, A., Dessypris, N., et al. (2007). Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: Two case-control studies. Oncology, 73, 261-269.
25. Howard, J. M., Beddy, P., Ennis, D., Keogan, M., Pidgeon, G. P., & Reynolds, J. V. (2010). Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. British Journal of Surgery, 97, 1020-1027.
26. Barresi, V., Grosso, M., Giuffre, G., Tuccari, G., & Barresi, G. (2009). The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. Journal of Clinical Pathology, 62, 705-709.
27. Tsukada, T., Fushida, S., Harada, S., Terai, S., Yagi, Y., Kinoshita, J., et al. (2011). Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. Journal of Experimental & Clinical Cancer Research, 30, 107.
28. Yamauchi, N., Takazawa, Y., Maeda, D., Hibiya, T., Tanaka, M., Iwabu, M., et al. (2012). Expression levels of adiponectin receptors are decreased in human endometrial adenocarcinoma tissues. International Journal of Gynecological Pathology, 31, 352-357.
29. Pfeiler, G., Hudelist, G., Wulfing, P., Mattsson, B., Konigsberg, R., Kubista, E., et al. (2010). Impact of AdipoR1 expression on breast cancer development. Gynecologic Oncology, 117, 134-138.
30. Byeon, J. S., Jeong, J. Y., Kim, M. J., Lee, S. M., Nam, W. H., Myung, S. J., et al. (2010). Adiponectin and adiponectin receptor in relation to colorectal cancer progression. International Journal of Cancer, 127, 2758-2767.
31. Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. The American Journal of Clinical Nutrition, 86, s858-s866.
32. Park, J. T., Yoo, T. H., Chang, T. I., Lee, D. H., Lee, J. H., Lee, J. E., et al. (2011). Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients. Metabolism: Clinical and Experimental, 60, 121-126.
33. Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., et al. (2002). Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America, 99, 16309-16313.
34. Choi, H. J., Kim, T. Y., Chung, N., Yim, J. H., Kim, W. G., Kim, J. A., et al. (2011). The influence of the BRAF V600E mutation in thyroid cancer cell lines on the anticancer effects of 5-aminoimidazole-4-carboxamide-ribonucleoside. Journal of Endocrinology, 211, 79-85.